Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 20/20 | 0.76 |
| ▸ | BRD2 | P25440 | 1/20 | 0.69 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.69 |
| ▸ | TSPO | P30536 | 1/20 | 0.69 |
| ▸ | EP300 | Q09472 | 1/20 | 0.69 |
| ▸ | BRD3 | Q15059 | 1/20 | 0.69 |
| ▸ | BRDT | Q58F21 | 1/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15069188 | 0.93 | BRD4 (0.68) | BRD4BRD2ADORA2BTSPOEP300 | |
| SCHEMBL15069423 | 0.91 | BRD4 (0.80) | BRD4BRD2ADORA2BTSPOEP300 | |
| SCHEMBL29437636 | 0.91 | BRD4 (0.80) | BRD4BRD2ADORA2BTSPOEP300 | |
| SCHEMBL15069275 | 0.91 | BRD4 (0.78) | BRD4BRD2ADORA2BTSPOEP300 | |
| SCHEMBL15771379 | 0.90 | BRD4 (0.63) | BRD4BRD2ADORA2BTSPOEP300 | |
| SCHEMBL25807335 | 0.89 | BRD4 (0.75) | BRD4BRD2ADORA2BTSPOEP300 | |
| SCHEMBL29437638 | 0.87 | BRD4 (0.73) | BRD4BRD2ADORA2BTSPOEP300 | |
| SCHEMBL28711505 | 0.87 | BRD4 (0.73) | BRD4BRD2ADORA2BTSPOEP300 | |
| SCHEMBL15069510 | 0.87 | BRD4 (0.79) | BRD4 | |
| SCHEMBL15069596 | 0.87 | BRD4 (1.00) | BRD4BRD2ADORA2BTSPOEP300 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025076236-A1 | METHODS AND COMPOUNDS FOR MODULATING HUNTINGTON'S DISEASE | Design Therapeutics, Inc. (US) | 2025-04-10 | — | — | WO | disclosed |
| WO-2025076219-A1 | METHODS AND COMPOUNDS FOR MODULATING HUNTINGTON'S DISEASE | Design Therapeutics, Inc. (US) | 2025-04-10 | — | — | WO | disclosed |
| WO-2025076181-A1 | METHODS AND COMPOUNDS FOR MODULATING HUNTINGTON'S DISEASE | Design Therapeutics, Inc. (US) | 2025-04-10 | — | — | WO | disclosed |